2024 Jeanny aragon-ching

Jeanny aragon-ching

Author: ehmt

August undefined, 2024

WebNov 20, 2024 · Jeanny B. Aragon-Ching, MD, FACP Author Bios Disclosures Dr. Jeanny B. Aragon-Ching Article Highlights Apalutamide, enzalutamide, and darolutamide are all novel antiandrogens that have been shown to improve metastasis-free survival, and all are approved by the FDA for nmCRPC. WebApr 13, 2024 · Results from the JAVELin Bladder 100 study support the use of avelumab as maintenance treatment for people with advanced urothelial cancer whose cancer has shrunk or not grown with first-line chemotherapy. WHAT IS THIS SUMMARY ABOUT? This is a plain language summary of an article originally published in The New England Journal of …

Dr. Jeanny Aragon-Ching, MD FAIRFAX, VA Oncology

WebUse Muck Rack to listen to ARASENS, TRITON3, and Other Key Advances at GU23 by ASCO Daily News and connect with podcast creators. WebMar 10, 2024 · Jeanny Aragon-Ching: Sam, thank you so much and for UroToday, too, for giving us a little bit of insights on the abstract that I presented at GU ASCO. So this is the treatment and survival differences in patients with urothelial versus non-urothelial bladder and upper tract carcinomas and analysis from the National Cancer Database. And as we ... gaffeltruck container

Jeanny Aragon-Ching - Clinical Program Director of

WebFollow the steps below to connect with the experts: 1. Get approval from Dr. Jeanny Aragon-ching. 2. Complete the new project intake form. 3. Once we receive your completed intake form, we will contact you within three business days. You may also sign-up for a quick meeting during our walk-in hours. More Information WebJeanny B Aragon-Ching Maintenance therapy with immune checkpoint inhibitors (ICIs) has changed the treatment paradigm of metastatic urothelial carcinoma (mUC). The JAVELIN … WebMar 4, 2024 · Plasmacytoid variant of urothelial carcinoma is a rare subtype of urothelial carcinoma that has poor prognosis. We describe two cases of patients with the plasmacytoid variant of urothelial carcinoma (PVUC) who had initial response to neoadjuvant chemotherapy followed by radical cystoprostatectomy and lymph node … gaf feltbuster synthetic roofing felt

‪Jeanny Aragon-Ching‬ - ‪Google Scholar‬

New Therapy Effective for Common, Advanced Bladder Cancer

WebSep 8, 2024 · Dr. Jeanny Aragon-Ching, MD is a hematology specialist in Fairfax, VA. Dr. Aragon-Ching completed a residency at Albert Einstein Medical Center. She currently … WebJeanny B. Aragon-Ching; Inger L. Rosner; Translational Andrology and Urology. Published on 01 Oct 2024. 0 views XX downloads; XX citations; 1760P Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Results from patients with ≥12 mo of treatment in JAVELIN Bladder 100. J.B. Aragon-Ching ... gaf feltbuster installation instructionsWebDec 10, 2024 · Dr. Jeanny Aragon-ching graduated from Other in 1997. Dr. Aragon-ching has one office in Virginia where she specializes in Hematology / Oncology, Hematology … gaffel t-shirt

"WebMay 29, 2008 · Jeanny Aragon-ching is an internist established in Falls Church, Virginia and her medical specialization is Internal Medicine with a focus in medical oncology with … " - Jeanny aragon-ching

Jeanny aragon-ching

Jeanny B. Aragon-Ching, MD, FACP - Bladder Cancer Advocacy …

WebFeb 20, 2024 · Long-term follow-up from the JAVELIN Bladder 100 trial confirms that avelumab 1L maintenance provides similar OS and PFS benefits in pts with advanced UC who are progression free following standard-of-care 1L cisplatin- or carboplatin-based chemotherapy, with an acceptable safety profile. 508 Background: For platinum-eligible … WebMar 10, 2024 · March 10, 2024. Sam Chang and Jeanny Aragon-Ching discuss treatment and survival differences in patients with urothelial versus non-urothelial bladder and upper …

Did you know?

Web, Jeanny B Aragon-Ching 4 Affiliations 1Virginia Commonwealth University, Department of Hematology, Oncology and Palliative Car. 2Inova Fairfax Hospital, Department of Internal … WebJeanny B Aragon-Ching has served on the Advisory Board of Amgen and Algeta/Bayer, and the Speakers’ Bureau of Astellas/Medivation and Janssen/Ortho-Biotech. All other authors have no conflicts of interest to disclose. References. 1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014.

WebMay 12, 2024 · Jeanny Aragon-Ching, MD, Clinical Program Director of Genitourinary Cancers at Inova Schar Cancer Institute, participated in two multi-institutional studies to better understand bladder cancer. WebJeannyB.Aragon-ChingMDFACP Oncology • Fairfax, VA Genitourinary Oncology Clinical Program Director of Genitourinary Cancers, INOVA Schar Cancer Institute; Associate …

WebJeanny Aragon-Ching Clinical Program Director GU Cancers, Inova Schar Cancer Institute Verified email at inova.org Prostate Cancer Bladder Cancer Kidney Cancer Genitourinary … WebJun 21, 2024 · Campbell Siefker-RadtkeAO. Optimizing management uppertract urothelial cancers. Urologic Oncol 2024;35:492–8. [13] Bagheri AhlmanMA, Lindenberg etal. Advances medicalimaging commongenitourinary cancers. Urolo Oncol 2024;35:473–91. J.B. Aragon-Ching UrologicOncology: Seminars OriginalInvestigations 35 (2024) 462–464 464

WebOct 28, 2015 · Aragon-Ching is a well-established clinician and has authored over 60 publications including papers in high-impact journals such as Clinical Cancer Research, Journal of Urology and the Lancet. Thomas Graves, FACHE has joined ISCI as Vice President for Cancer Services and Associate Director for Administration. Mr.

WebOct 10, 2024 · Aragon-Ching: JAVELIN Bladder 100 is a phase 3, international, randomized trial in locally advanced and metastatic urothelial carcinoma. This trial investigated the use of chemotherapy with... gaffe marineWebDr. Jeanny B. Aragon-Ching is an Internal Medicine Doctor in Fairfax, VA with special training and skill in the diagnosis, treatment, and care of adults across the spectrum from … gaf felt buster underlayments specificationsWebJeanny B. Aragon-Ching, MD has been registered with the National Provider Identifier database since May 29, 2008, and her NPI number is 1376701946. Dr. Aragon-Ching certified her NPI information on 09/10/2024. Book an Appointment. To schedule an appointment with Dr. Jeanny B. Aragon-Ching, please call (571) 472-4724. gaffe miniaturesWebJeanny B. Aragon-Ching, M.D., F.A.C.P. serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute in Fairfax, Virginia, with a joint … black and white framed wall picturesWebJeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as … black and white framed prints for saleWebJeanny B. Aragon-Ching, M.D. Dr. Aragon-Ching is a specialty Oncology care physician board certified in medical oncology, hematology and internal medicine. She joins Inova … black and white framed sayingsWebSep 21, 2024 · Jeanny B. Aragon-Ching, MD, FACP, clinical program director, Genitourinary Cancers, the Inova Schar Cancer Institute, discusses the clinical implications of the phase 3 JAVELIN Bladder 100 ... black and white framed wall decor